Cleveland Clinic Cardiovascular Update 2025
$25,00
This Product is shared via google drive download link, So please share your correct Gmail id while placing the order .Please note that there are no CME points or certificate associated with this course Samples for Courses Can be found here : Free Samples Here!
Cleveland Clinic
Cardiovascular Update
| Session 1: Prevention and Management of Cardiovascular Risk, Part 1 | |
| Tools in CVD Prevention and Risk Management: To Test or Not to Test? Lp(a),apoB, Non HDL-C | Dennis Bruemmer, MD, PhD |
| Statin Initiation for Primary Prevention Among Statin Naïve Adults and Reasons for Nonadherence | Vikas Sunder, MD |
| When Statins Are Not Enough – Non-statin Lipid Lowering Therapies to Manage Residual Risk | Ashish Sarraju, MD |
| Managing Anti-Hyperglycemic and CV Risk Reduction Agents in Patients With Diabetes: SGLT2i or GLP1RA or Both? | Dennis Bruemmer, MD, PhD |
| Weight Loss Pharmacotherapy: Utilizing Current Therapies and Exploring the Next Generation of Weight Loss Medications | Steve Nissen, MD |
| Keto, Low Carb, Plant Based, IF: Controversies in the Evidence for the “Best “Diet: What is the Evidence and How to Apply in Clinical Practice | Julia Zumpano, RD, LD |
| Old and Evolving Strategies for Treatment-Resistant Hypertension | Luke Laffin, MD |
| Social Determinants of Health and Cardiovascular Disease: Current State and Future Directions | Lee Kirksey, MD |
| Panel Discussion/Q&A | Session Faculty |
| Session 2: Prevention and Management of Cardiovascular Risk, Part 2 | |
| Hormone Therapy and Heart Health: Debunking Myths, Embracing Evidence | Luke Laffin, MD |
| The Intersection of Cardiovascular Disease and Chronic Kidney Disease: Strategies for Reducing Cardiovascular Risk | Crystal Gadegbeku, MD |
| Who Should Get a CAC? How Often? How to Use the Results to Assess Risk? | Milind Desai, MD |
| Management of CV Issues in the Elderly: Geriatric Cardiology | Ardeshir Hashmi, MD |
| Population Health Management: Interventions to Control Cardiovascular Disease Risk Factors: Current Status | LeRoi Hicks, MD |
| Panel Discussion/Q&A | Session Faculty |
| Session 3: Special Populations | |
| Cardiac Disease Remains the Leading Cause of Mortality in Women: What are we Doing to Address This? | Vikas Sunder, MD |
| Cardiovascular Disease and Pregnancy: Optimizing Maternal and Fetal Health | Deirdre Mattina, MD |
| Competitive Sports Participation in Athletes with Heart Disease: Evaluation and Management | Tamanna Singh, MD |
| Cardio-oncology: Optimizing the Balance Between Cancer Outcomes and Cardiac Success | Patrick Collier, MD, PhD |
| Panel Discussion/Q&A | Session Faculty |
| Session 4: Essentials of Cardiovascular Disease | |
| Role of Advanced Imaging for Ischemic Heart Disease: CT, CMR, Nuclear and Advanced Echocardiography | Saberio Lo Presti Vega, MD |
| Creating a Pathway for the Management of Stable Angina in Your Clinic: Structured Risk Assessment and Clinical Decision Making | Ben Alencherry, MD |
| ANOCA, INOCA, MINOCA: What Does It All Mean? Diagnostic Testing and Therapeutic Management | Khalid Ziada, MD |
| How Do I Manage my Post MI Patient (Including DAPT Guidelines/Duration/CardiacRehab) | Venu Menon, MD |
| Cardiac Rehab: Why it is Critical and How Can We Improve Access and Compliance? | Erik Van Iterson, PhD, MS |
| Peripheral Artery Disease: Assessment and Clinical Decision Making | Lee Kirksey, MD |
| Panel Discussion/Q&A | Session Faculty |
| Session 5: Structural Heart Disease | |
| Aortic Stenosis: Diagnosis and Management in the Modern Era | Samir Kapadia, MD |
| MR: How to Diagnose and Manage Mitral Valve Disease: When to Refer? What are the Options | L. Leonardo Rodriguez, MD |
| What to Know About the Natural History of Tricuspid Regurgitation: Current and Future Management Strategies | Amar Krishnaswamy, MD |
| Bicuspid and Aneurysm-Associated Aortic Valve Disease: Timing of Intervention and the Role of Family Screening | Milind Desai, MD |
| Guidelines for Anticoagulation Following Structural Heart Therapies | Grant Reed, MD, MSc |
| Hypertrophic Cardiomyopathy: Co-management in the Era of Emerging Precision Therapies | Milind Desai, MD |
| Panel Discussion/Q&A | Session Faculty |
| Session 6: Heart Failure | |
| Heart Failure Stages, Phenotypes and Diagnosis and How to Screen for HF in the Primary Care Setting | Randall Starling, MD |
| HFrEF: Essentials of Guideline Directed Medical Therapy Initiation and Titration | Amanda Vest, MBBS |
| Managing Comorbidities in HF: Frailty, Anemia, Sleep Apnea, AF, Obesity | Karlee Hoffman, DO |
| Essentials of Diagnosis and Management for HFpEF | Sanjeeb Bhattacharya, MD |
| Diagnosis and Management of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) | Mazen Hanna, MD |
| Strategies to Enhance GDMT Implementation and Adherence | M. Trejeeve Martyn, MD |
| Managing Long Term LVADs and Transplant Recipients in the Community Setting | Ike Okwuosa, MD |
| The Importance of Collaboration Between EP and HF: CRT and Novel Pacing | Niraj Varma, MD, PhD |
| Panel Discussion/Q&A | Session Faculty |
| Session 7: Heart Rhythm | |
| Diagnosis and Management of New-Onset Atrial Fibrillation | Mohamed Kanj, MD |
| AF and Left Atrial Appendage Closure: Current and Future Directions | Mohamed Kanj, MD |
| What I Need to Know to Evaluate and Manage the Patient With PVCs and SVT | Pasquale Santangeli, MD, PhD |
| Evaluation and Management of Syncope in the Young Adult | Kenneth Mayuga, MD |
| Follow-Up of Pacemakers and ICDs For the Non-Electrophysiologist | Kevin F. Kwaku, MD, PhD |
| Wearables for Arrhythmia Care: Current Challenges and Future Prospects | Niraj Varma, MD, PhD |
| Panel Discussion/Q&A | Session Faculty |
End
Related products
CRITICAL CARE / EMERGENCY MEDICINE
Bringing Best Practices to Your ICU: An Interdisciplinary Approach 2019
$15,00
CRITICAL CARE / EMERGENCY MEDICINE
AAFP Emergency and Urgent Care Self-Study Package 10th Edition 2020 (CME VIDEOS)
$35,00
CRITICAL CARE / EMERGENCY MEDICINE
$10,00
CRITICAL CARE / EMERGENCY MEDICINE
Harvard Advanced Trauma Management for the Emergency Physician 2022 (CME VIDEOS)
$25,00
CRITICAL CARE / EMERGENCY MEDICINE
$15,00
$80,00
CRITICAL CARE / EMERGENCY MEDICINE
$15,00